All In MedTech

PMA device

Flow Re-Direction Endoluminal Device (FRED®) System

MicroVention, Inc. · Intracranial Aneurysm Flow Diverter (OUT, Class III) · First FDA decision Dec 16, 2019, newest Nov 2, 2025Brain aneurysm

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

5

PMA pathway

Device trials

8

Naming "Flow Re-Direction Endoluminal"

MAUDE reports

3

Brand "Flow Re-Direction Endoluminal", since 2015

PubMed studies

48

Mentioning "Flow Re-Direction Endoluminal"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Flow Re-Direction Endoluminal Device (FRED®) System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology, with pictures of the device
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 5 of 5 decisions filed under this name.

4 more FDA decisions with a free account

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "Flow Re-Direction Endoluminal", any status and sponsor, newest update first.

Open in Trial Radar

7 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Flow Re-Direction Endoluminal", and for the whole product code for context.

This brand

3 reports: 0 malfunction, 3 injury, 0 death

Whole product code OUT

10,961 reports: 7,308 malfunction, 3,152 injury, 499 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "Flow Re-Direction Endoluminal"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code OUT.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.